Kavar Capital Partners Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-6	Closed	–	–	140
2014 Q1	$0	Sell	6 -2	-25%	–	﹤0.01%	529
2013 Q4	$0	Buy	+8	New	–	﹤0.01%	499